Healthy volunteers help check if two drug versions are equal
NCT ID NCT06360081
First seen Nov 01, 2025
Summary
This study tested whether two different manufacturing versions of the drug zongertinib are absorbed the same way in the body. Fifty-six healthy adults took a single dose of each version at different times. The goal was to see if the two versions are bioequivalent, meaning they produce similar drug levels in the blood. No treatment or disease was involved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.